# Menopause Estrogen Patches Face Supply Shortage, Limiting Treatment Options
Estrogen patches, a primary hormone replacement therapy for menopause symptoms, face significant supply constraints. Women seeking relief from hot flashes, night sweats, and vaginal dryness now encounter longer wait times and limited availability at pharmacies.
The shortage stems from manufacturing disruptions and increased demand as more women opt for hormone replacement therapy after years of hesitation following the 2002 Women's Health Initiative study. That research linked combined estrogen-progestin therapy to breast cancer risk, though later analysis showed the danger applied mainly to specific formulations and older women.
For women unable to access patches, alternatives exist. Oral estrogen tablets work effectively but bypass the liver differently than patches, potentially carrying higher clot risks. Vaginal creams and rings deliver localized hormone therapy for vaginal symptoms specifically. Non-hormone options including SSRIs like paroxetine reduce hot flashes by 60 percent in some patients. Gabapentin, an anti-seizure medication, provides another non-hormone avenue.
Women should consult their doctors about which option fits their symptoms and health history. The patch shortage remains temporary, but alternatives ensure treatment needn't stop while supply recovers.